Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A trial of three antiretroviral regimens in HIV-1-infected children.

The New England journal of medicine - 10 Jun 2004

Luzuriaga Katherine, McManus Margaret, Mofenson Lynne, Britto Paula, Graham Bobbie, Sullivan John L

Abstract excerpt

BACKGROUND: Depletion of CD4 T-cell counts or progression of human immunodeficiency virus (HIV) disease occurs rapidly in children, but few data address the efficacy of aggressive therapy for HIV-infected children. METHODS: We evaluated the safety, tolerability, and activity of three regimens of antiretroviral therapy in a multicenter, open-label, phase 1-2 trial. Children infected with HIV type 1 (HIV-1) were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chi-Square Distribution

Share to Drug Resistance, Viral

Share to Drug Therapy, Combination

Share to Logistic Models

Share to Viral Load

Share to Virus Replication

Source

Identifiers

PMID: 15190139
DOI: 10.1056/NEJMoa032706

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A trial of three antiretroviral regimens in HIV-1-infected children.PMID 15190139Read ↗

Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study.Semantic proximity Read ↗

Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants.Semantic proximity Read ↗

The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076).Semantic proximity Read ↗

HIV ‐1 DNA decay is faster in children who initiate ART shortly after birth than laterSemantic proximity Read ↗

HIV-1 infection in Kenyan infants : natural history and T cell responsesSemantic proximity Read ↗

Genotype-guided antiretroviral regimens in children with multidrug-resistant HIV-1 infection.Semantic proximity Read ↗

Long-term Virologic Suppression Despite Presence of Resistance-associated Mutations Among Perinatally HIV-infected Youth.Semantic proximity Read ↗

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.Semantic proximity Read ↗

Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected InfantsSemantic proximity Read ↗

Early Treatment Regimens Achieve Sustained Virologic Remission in Infant Macaques Infected with SIV at BirthSemantic proximity Read ↗

Effect of first line therapy including efavirenz and two nucleoside reverse transcriptase inhibitors in HIV-infected children.Semantic proximity Read ↗

Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.